| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell-Free Nucleic Acids | 8 | 2025 | 84 | 4.470 |
Why?
|
| Computational Biology | 13 | 2018 | 556 | 3.430 |
Why?
|
| Gene Expression Profiling | 22 | 2019 | 1465 | 2.740 |
Why?
|
| Algorithms | 20 | 2018 | 1933 | 2.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 12 | 2011 | 694 | 2.230 |
Why?
|
| DNA Methylation | 9 | 2025 | 672 | 1.760 |
Why?
|
| Genomics | 8 | 2015 | 793 | 1.680 |
Why?
|
| Software | 12 | 2023 | 670 | 1.660 |
Why?
|
| Databases, Genetic | 9 | 2015 | 270 | 1.650 |
Why?
|
| Gene Regulatory Networks | 8 | 2015 | 309 | 1.570 |
Why?
|
| Chromatin | 8 | 2023 | 410 | 1.450 |
Why?
|
| Genome, Human | 7 | 2016 | 794 | 1.210 |
Why?
|
| Neoplasms | 8 | 2023 | 3053 | 1.140 |
Why?
|
| Protein Isoforms | 3 | 2016 | 281 | 0.990 |
Why?
|
| Genome | 6 | 2023 | 395 | 0.950 |
Why?
|
| MicroRNAs | 5 | 2014 | 568 | 0.930 |
Why?
|
| Sequence Analysis, RNA | 4 | 2015 | 243 | 0.900 |
Why?
|
| Alternative Splicing | 3 | 2016 | 214 | 0.880 |
Why?
|
| Disease | 2 | 2014 | 90 | 0.730 |
Why?
|
| Circulating Tumor DNA | 1 | 2021 | 48 | 0.710 |
Why?
|
| Biomarkers, Tumor | 8 | 2025 | 1559 | 0.690 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 241 | 0.670 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 532 | 0.660 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 1163 | 0.650 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 2440 | 0.650 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 291 | 0.650 |
Why?
|
| Epigenomics | 3 | 2017 | 103 | 0.640 |
Why?
|
| Chromosomes | 5 | 2023 | 99 | 0.640 |
Why?
|
| Phenotype | 6 | 2015 | 2480 | 0.590 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 530 | 0.580 |
Why?
|
| Humans | 50 | 2025 | 91073 | 0.580 |
Why?
|
| Chromosome Mapping | 4 | 2017 | 1079 | 0.570 |
Why?
|
| Genome-Wide Association Study | 5 | 2013 | 1713 | 0.540 |
Why?
|
| Databases, Protein | 4 | 2012 | 51 | 0.540 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 1993 | 0.530 |
Why?
|
| Models, Genetic | 5 | 2015 | 962 | 0.520 |
Why?
|
| Bayes Theorem | 3 | 2013 | 386 | 0.510 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2025 | 404 | 0.510 |
Why?
|
| Sepsis | 1 | 2020 | 330 | 0.510 |
Why?
|
| Gene Expression | 5 | 2015 | 1313 | 0.510 |
Why?
|
| Chromosomes, Human | 2 | 2016 | 65 | 0.500 |
Why?
|
| Linear Models | 2 | 2014 | 426 | 0.500 |
Why?
|
| Cell Physiological Phenomena | 1 | 2015 | 24 | 0.500 |
Why?
|
| Computer Simulation | 6 | 2021 | 1105 | 0.480 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2023 | 493 | 0.470 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 784 | 0.470 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 763 | 0.440 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 71 | 0.440 |
Why?
|
| Ovarian Neoplasms | 4 | 2014 | 779 | 0.430 |
Why?
|
| Extracellular Vesicles | 2 | 2025 | 43 | 0.430 |
Why?
|
| Pattern Recognition, Automated | 3 | 2010 | 221 | 0.420 |
Why?
|
| Protein Interaction Mapping | 2 | 2014 | 81 | 0.410 |
Why?
|
| Signal Transduction | 3 | 2008 | 3442 | 0.380 |
Why?
|
| Proteome | 2 | 2016 | 142 | 0.380 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2011 | 46 | 0.370 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 982 | 0.370 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 181 | 0.370 |
Why?
|
| Multifactorial Inheritance | 1 | 2013 | 180 | 0.370 |
Why?
|
| RNA Splicing | 1 | 2012 | 157 | 0.360 |
Why?
|
| DNA | 2 | 2015 | 1313 | 0.350 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 203 | 0.340 |
Why?
|
| Information Storage and Retrieval | 2 | 2010 | 122 | 0.340 |
Why?
|
| Cluster Analysis | 4 | 2012 | 373 | 0.310 |
Why?
|
| Datasets as Topic | 2 | 2021 | 77 | 0.290 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 427 | 0.290 |
Why?
|
| Fungal Proteins | 2 | 2005 | 142 | 0.280 |
Why?
|
| CpG Islands | 2 | 2018 | 160 | 0.280 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 266 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 1295 | 0.270 |
Why?
|
| Database Management Systems | 1 | 2006 | 41 | 0.270 |
Why?
|
| Biomarkers | 3 | 2023 | 1814 | 0.260 |
Why?
|
| Transcription Factors | 4 | 2017 | 1671 | 0.250 |
Why?
|
| Cell Nucleus | 3 | 2023 | 607 | 0.250 |
Why?
|
| Models, Statistical | 3 | 2017 | 577 | 0.250 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 520 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 872 | 0.240 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2033 | 0.240 |
Why?
|
| Data Interpretation, Statistical | 4 | 2014 | 304 | 0.240 |
Why?
|
| Data Mining | 2 | 2017 | 44 | 0.240 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2005 | 63 | 0.230 |
Why?
|
| Natural Killer T-Cells | 1 | 2024 | 46 | 0.220 |
Why?
|
| Models, Biological | 3 | 2018 | 1771 | 0.210 |
Why?
|
| Animals | 16 | 2024 | 27783 | 0.210 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 198 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 3 | 2023 | 964 | 0.210 |
Why?
|
| Internet | 3 | 2014 | 324 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 606 | 0.210 |
Why?
|
| Likelihood Functions | 3 | 2016 | 252 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2024 | 308 | 0.200 |
Why?
|
| Computer Graphics | 3 | 2007 | 100 | 0.190 |
Why?
|
| Mutation | 3 | 2023 | 4203 | 0.190 |
Why?
|
| Aging | 1 | 2006 | 732 | 0.190 |
Why?
|
| Methylation | 2 | 2020 | 276 | 0.190 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 245 | 0.190 |
Why?
|
| Databases, Factual | 2 | 2019 | 882 | 0.190 |
Why?
|
| Exome | 1 | 2022 | 131 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2785 | 0.190 |
Why?
|
| Neoplasm, Residual | 1 | 2022 | 185 | 0.180 |
Why?
|
| Liquid Biopsy | 1 | 2020 | 37 | 0.180 |
Why?
|
| Heterochromatin | 2 | 2017 | 24 | 0.180 |
Why?
|
| Regression Analysis | 2 | 2012 | 590 | 0.170 |
Why?
|
| Markov Chains | 2 | 2013 | 130 | 0.170 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 175 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 481 | 0.170 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 246 | 0.160 |
Why?
|
| Female | 9 | 2025 | 47186 | 0.160 |
Why?
|
| Centromere | 2 | 2016 | 26 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2012 | 429 | 0.150 |
Why?
|
| Cell Line | 4 | 2016 | 2506 | 0.150 |
Why?
|
| Cytological Techniques | 1 | 2018 | 31 | 0.150 |
Why?
|
| Molecular Conformation | 1 | 2018 | 99 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 669 | 0.150 |
Why?
|
| Chromosomes, Insect | 1 | 2017 | 8 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 613 | 0.140 |
Why?
|
| Biopsy | 1 | 2021 | 1196 | 0.140 |
Why?
|
| Prognosis | 2 | 2025 | 3825 | 0.140 |
Why?
|
| User-Computer Interface | 2 | 2010 | 187 | 0.140 |
Why?
|
| Genome, Insect | 1 | 2017 | 78 | 0.140 |
Why?
|
| Mass Screening | 1 | 2021 | 646 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2020 | 0.130 |
Why?
|
| Workflow | 1 | 2017 | 81 | 0.130 |
Why?
|
| Genotype | 2 | 2013 | 1858 | 0.130 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2013 | 16 | 0.130 |
Why?
|
| Protein Interaction Maps | 2 | 2016 | 51 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2020 | 407 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2024 | 1564 | 0.130 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 353 | 0.130 |
Why?
|
| ROC Curve | 1 | 2018 | 785 | 0.130 |
Why?
|
| Genes, Essential | 1 | 2015 | 20 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1374 | 0.130 |
Why?
|
| Bacteria | 1 | 2020 | 497 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 968 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2018 | 342 | 0.120 |
Why?
|
| Nucleosomes | 2 | 2012 | 57 | 0.120 |
Why?
|
| Chromosomes, Fungal | 1 | 2015 | 15 | 0.120 |
Why?
|
| Metagenomics | 1 | 2016 | 94 | 0.120 |
Why?
|
| Saccharomycetales | 1 | 2015 | 11 | 0.120 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 39 | 0.120 |
Why?
|
| Genome, Fungal | 1 | 2015 | 34 | 0.120 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 615 | 0.120 |
Why?
|
| Genomic Library | 1 | 2014 | 33 | 0.120 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 26 | 0.120 |
Why?
|
| Papio | 1 | 2015 | 83 | 0.120 |
Why?
|
| Schizosaccharomyces | 1 | 2015 | 56 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2022 | 1500 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 101 | 0.110 |
Why?
|
| Forecasting | 1 | 2015 | 307 | 0.110 |
Why?
|
| RNA Isoforms | 1 | 2013 | 5 | 0.110 |
Why?
|
| Mice | 5 | 2024 | 11993 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2014 | 69 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 3029 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 173 | 0.110 |
Why?
|
| Species Specificity | 2 | 2006 | 690 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 129 | 0.110 |
Why?
|
| Pan troglodytes | 1 | 2015 | 205 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2025 | 8436 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 188 | 0.100 |
Why?
|
| Population Groups | 1 | 2012 | 41 | 0.100 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 41 | 0.100 |
Why?
|
| Oncogenes | 1 | 2012 | 97 | 0.100 |
Why?
|
| Drosophila Proteins | 2 | 2017 | 511 | 0.100 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 99 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 163 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 589 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 96 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 3031 | 0.090 |
Why?
|
| Exons | 1 | 2012 | 453 | 0.090 |
Why?
|
| Comorbidity | 1 | 2014 | 963 | 0.090 |
Why?
|
| Postmortem Changes | 1 | 2010 | 8 | 0.090 |
Why?
|
| Histones | 1 | 2012 | 345 | 0.090 |
Why?
|
| Access to Information | 1 | 2010 | 28 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 289 | 0.080 |
Why?
|
| Unified Medical Language System | 1 | 2009 | 1 | 0.080 |
Why?
|
| Middle Aged | 3 | 2025 | 26555 | 0.080 |
Why?
|
| Biometry | 1 | 2009 | 67 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2380 | 0.080 |
Why?
|
| Systems Biology | 1 | 2009 | 44 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 2375 | 0.080 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 17 | 0.070 |
Why?
|
| Precision Medicine | 2 | 2022 | 421 | 0.070 |
Why?
|
| Diploidy | 2 | 2018 | 31 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1723 | 0.070 |
Why?
|
| Transcriptome | 1 | 2012 | 679 | 0.070 |
Why?
|
| Male | 4 | 2025 | 43249 | 0.070 |
Why?
|
| Systems Integration | 1 | 2006 | 35 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2016 | 1327 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 452 | 0.070 |
Why?
|
| Sample Size | 1 | 2006 | 125 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2017 | 355 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 294 | 0.060 |
Why?
|
| Adult | 2 | 2025 | 27147 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 800 | 0.060 |
Why?
|
| Genes, Fungal | 1 | 2005 | 58 | 0.060 |
Why?
|
| Aged | 3 | 2025 | 19574 | 0.060 |
Why?
|
| Binding Sites | 1 | 2007 | 1127 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2005 | 234 | 0.060 |
Why?
|
| Asthma | 1 | 2012 | 994 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2024 | 76 | 0.050 |
Why?
|
| Base Sequence | 1 | 2007 | 2329 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1508 | 0.050 |
Why?
|
| Glypicans | 1 | 2023 | 6 | 0.050 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 82 | 0.050 |
Why?
|
| Polycomb-Group Proteins | 2 | 2012 | 9 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 887 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 410 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 70 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1877 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2023 | 498 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 4043 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 13 | 0.040 |
Why?
|
| Proteomics | 1 | 2021 | 242 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 2327 | 0.040 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 621 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6847 | 0.040 |
Why?
|
| Exosomes | 1 | 2019 | 55 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 156 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 67 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 60 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 202 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 196 | 0.030 |
Why?
|
| Chromosome Positioning | 1 | 2016 | 4 | 0.030 |
Why?
|
| Tomography, X-Ray | 1 | 2016 | 18 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2023 | 1237 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2016 | 79 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 87 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 121 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 35 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 646 | 0.030 |
Why?
|
| Primates | 1 | 2016 | 155 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 120 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 119 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1493 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 166 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2016 | 470 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2345 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 253 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2015 | 182 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 742 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 50 | 0.030 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2012 | 10 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 731 | 0.030 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2012 | 32 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 154 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2012 | 78 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 137 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 202 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 103 | 0.020 |
Why?
|
| Azacitidine | 1 | 2013 | 148 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 178 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 181 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 9399 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2015 | 522 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 465 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 859 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 453 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2077 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 766 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2016 | 988 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3303 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2615 | 0.020 |
Why?
|